[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370530-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370530-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nucleolar-sequestration-of-cannabinoid-type-2-receptors-in-triple-negative-breast-cancer-cells-research-article","Nucleolar sequestration of cannabinoid type-2 receptors in triple-negative breast cancer cells - Research Article","","Study investigates how cannabinoid type-2 receptor (CB2R) is expressed and where it localizes inside cells of triple-negative breast cancer. Using immunocytochemistry and confocal microscopy, CB2R is compared between early-stage (HCC-1395), metastatic (MDA-MB-231) TNBC cell lines and non-tumoral mammary epithelial cells (MCF-10A). CB2R is mainly intracellular, with ~40-fold higher expression in TNBC, predominantly in nucleoli, and reduced in mitosis. HU-308 agonist reverses nucleolar sequestration, increases receptor in nucleoplasm and cytoplasm, and decreases TNBC migration and proliferation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nucleolar-sequestration-of-cannabinoid-type-2-receptors-in-triple-negative-breast-cancer-cells-research-article/370530/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nucleolar-sequestration-of-cannabinoid-type-2-receptors-in-triple-negative-breast-cancer-cells-research-article/370530.png","ImageObject",300,407,{"name":42,"@type":43},"Sophia Brooks","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-21","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was CB2R expression and localization measured in the TNBC cell lines?","Question",{"text":63,"@type":64},"The study used immunocytochemistry and confocal microscopy to assess CB2R expression level and subcellular localization in early-stage and metastatic TNBC cell lines, compared with a non-tumoral mammary epithelial line.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Where is CB2R mainly localized in the cancer cells, and how does it differ from non-tumoral cells?",{"text":68,"@type":64},"Although CB2R is detected at the plasma membrane, it is mainly localized intracellularly, with ~40-fold higher expression in TNBC cells than in MCF-10A. Double staining indicates most CB2R overexpression occurs in nucleoli.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the effect of the CB2R agonist HU-308 on CB2R sequestration and TNBC cell behavior?",{"text":72,"@type":64},"HU-308 reverses nucleolar sequestration of CB2R, increasing its presence in nucleoplasm and cytoplasm. The agonist also reduces TNBC cell migration and proliferation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370530,1790712008,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","OPEN ACCESS  \nCitation: Prado-Celis LP, Zamora-Cardenas R, Alamilla J, Sanchez-Pastor EA, Ferrer T, Moreno-Galindo EG, et al. (2025) Nucleolar sequestration of cannabinoid type-2 receptors in triple-negative breast cancer cells. PLoSOne 20(5): e0323554. [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pone.0323554](journal.pone.0323554)  \nEditor: Muhammad Ahmad, Institute of Physiology and Pharmacology, University of Agriculture Faisalabad, PAKISTAN  \nReceived: October 22, 2024  \nAccepted: April 10, 2025  \nPublished: May 13, 2025  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0323554  \nCopyright: © 2025 Prado-Celis et al. This is an open access article distributed under the terms of the Creative Commons Attribution License,  \nRESEARCH ARTICLE  \nNucleolar sequestration of cannabinoid type-2 receptors in triple-negative breast cancer cells  \nLinley P. Prado-Celis1, Rodrigo Zamora-Cárdenas1, Javier Alamilla1,2, Enrique A. Sánchez-Pastor1, Tania Ferrer1, Eloy G. Moreno-Galindo1*, Ricardo A. Navarro-Polanco1*  \n1 Centro Universitario de Investigaciones Biomédicas “CUIB”, Universidad de Colima, Colima, Colima, Mexico, 2 Consejo Nacional de Humanidades, Ciencia y Tecnología (CONAHCYT), Universidad de Colima, Colima, Mexico  \n* [magdal@ucol.mx](magdal@ucol.mx) (RANP); [eloy@ucol.mx](eloy@ucol.mx) (EGMG)  \nAbstract  \nMultiple investigations have shown that the different types of cannabinoids, phytocannabinoids, synthetic cannabinoids, and endocannabinoids, possess antiproliferative and anticancer properties. The cannabinoid type-2 receptor (CB2R) has been proposed as a central player in tumor progression and has been correlated with the aggressiveness of breast cancer. Using immunocytochemistry and confocal microscopy, in the present work, we studied the expression level and subcellular localization of CB2R in two human triple-negative breast cancer (TNBC) cell lines, corresponding to early (stage I, HCC-1395) and metastatic (MDA-MB-231) stages, and they were compared with a non-tumoral mammary epithelial cell line (MCF-10A) . We found that although CB2R was detected at the plasma membrane, it was mainly localized intracellularly, with ~40-fold higher expression in both TNBC cell lines than in MCF-10A (P \u003C 0.0001) . Notably, double staining with DAPI or with the nucleoli-specific fluorescent marker (3xnls-mTurquoise2) showed that most of the CB2R overexpressed in the nucleoli of cancer cells. This finding is supported by the fact that CB2R expression was markedly lower in mitotic cells compared to interphase cells (P \u003C 0.0001) . Interestingly, exposure of cancer cells to the specific agonist HU-308 reversed thenucleolar sequestration of CB2R while increasing the presence of the receptor in the nucleoplasm and cytoplasm (P \u003C 0.0001) . In addition, we found that this agonist reduced both the cell migration (P \u003C 0.05–0.0001) and proliferation (P \u003C 0.001) of TNBC cells. It remains to determine the function and signaling ability of CB2R in the nucleolus. Although our study only includes cell lines (tumoral and non-tumoral), we consider that this feature of nucleolar sequestration of CB2R could be a potential diagnostic marker for TNBC from the early stage.  \nPLOS One | [https://doi.org/10.1371/journal.pone.0323554](https://doi.org/10.1371/journal.pone.0323554) May 13, 2025 1 / 13  \nwhich permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All relevant data are within the manuscript and its Supporting  Information files.  \nFunding: This work was funded by Consejo Nacional de Humanidades, Cienc","cbCaipY8qOkNh0iq","https://ap.wps.com/l/cbCaipY8qOkNh0iq","pdf",1285080,13,"English","# Abstract\n## CB2R expression and subcellular localization\n## Nucleolar enrichment and cell cycle dependence\n## HU-308 effects on sequestration and TNBC behavior\n## Study implications","[{\"question\":\"How was CB2R expression and localization measured in the TNBC cell lines?\",\"answer\":\"The study used immunocytochemistry and confocal microscopy to assess CB2R expression level and subcellular localization in early-stage and metastatic TNBC cell lines, compared with a non-tumoral mammary epithelial line.\"},{\"question\":\"Where is CB2R mainly localized in the cancer cells, and how does it differ from non-tumoral cells?\",\"answer\":\"Although CB2R is detected at the plasma membrane, it is mainly localized intracellularly, with ~40-fold higher expression in TNBC cells than in MCF-10A. Double staining indicates most CB2R overexpression occurs in nucleoli.\"},{\"question\":\"What is the effect of the CB2R agonist HU-308 on CB2R sequestration and TNBC cell behavior?\",\"answer\":\"HU-308 reverses nucleolar sequestration of CB2R, increasing its presence in nucleoplasm and cytoplasm. The agonist also reduces TNBC cell migration and proliferation.\"}]","Nucleolar sequestration of cannabinoid type-2 receptors in triple-negative breast cancer cells - Research Article | PDF",1790189017,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/809370d0dc78189413e8be23b37fc634.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e62a11f708e54fa25c5cfa076e6399e1.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc6911d4f93236808f7601abb68151e5.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19e29b80dd0556500126116c8fb3d290.webp",980,1268]